National Standards and Oversight Resources
Guidelines & Regulatory Efforts Supporting Anticoagulation Stewardship
Explore essential guidelines and regulatory efforts shaping anticoagulation stewardship. This page highlights key initiatives and updates designed to improve anticoagulant management and patient safety.
National Action Plan for ADE Prevention
The National Action Plan for Adverse Drug Event (ADE) Prevention highlights the significant prevalence of avoidable adverse events associated with anticoagulation therapy. It underscores the need for future public health initiatives to adopt a comprehensive approach that prioritizes both the safety and effectiveness of anticoagulants in order to reduce these preventable harms.
Learn More
Joint Commission 2024 National Patient Safety Goals
The Joint Commission updated National Patient Safety Goal (NPSG), effective January 1, 2024, in response to the increasing incidence of adverse drug events associated with direct oral anticoagulants (DOACs). These changes aim to enhance the safety and effectiveness of anticoagulation therapy and reduce the risk of adverse events.
Learn More
Pharmacy Quality Alliance Quality Measure: Adherence to Direct-Acting Oral Anticoagulants
Learn More
Pharmacy Quality Alliance Quality Measure: International Normalized Ratio Monitoring for Individuals on Warfarin
Learn More
Explore essential guidelines and regulatory efforts shaping anticoagulation stewardship. This page highlights key initiatives and updates designed to improve anticoagulant management and patient safety.
National Action Plan for ADE Prevention
The National Action Plan for Adverse Drug Event (ADE) Prevention highlights the significant prevalence of avoidable adverse events associated with anticoagulation therapy. It underscores the need for future public health initiatives to adopt a comprehensive approach that prioritizes both the safety and effectiveness of anticoagulants in order to reduce these preventable harms.
Learn MoreJoint Commission 2024 National Patient Safety Goals
The Joint Commission updated National Patient Safety Goal (NPSG), effective January 1, 2024, in response to the increasing incidence of adverse drug events associated with direct oral anticoagulants (DOACs). These changes aim to enhance the safety and effectiveness of anticoagulation therapy and reduce the risk of adverse events.
Learn MorePharmacy Quality Alliance Quality Measure: Adherence to Direct-Acting Oral Anticoagulants
Learn MorePharmacy Quality Alliance Quality Measure: International Normalized Ratio Monitoring for Individuals on Warfarin
Learn MoreProfessional Society Positions and Resources
Discover organizations that support anticoagulation stewardship. Learn about key professional societies that have endorsed or aligned with AC stewardship initiatives, providing valuable resources and guidance for healthcare providers.